Skip to main content

Peer Review reports

From: Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)

Original Submission
17 Nov 2018 Submitted Original manuscript
23 Apr 2019 Author responded Author comments - China Nagano
Resubmission - Version 2
23 Apr 2019 Submitted Manuscript version 2
8 Jun 2019 Reviewed Reviewer Report - Arvind Bagga
10 Jun 2019 Reviewed Reviewer Report - A Segarra
26 Jun 2019 Author responded Author comments - China Nagano
Resubmission - Version 3
26 Jun 2019 Submitted Manuscript version 3
29 Jun 2019 Reviewed Reviewer Report - A Segarra
7 Jul 2019 Reviewed Reviewer Report - Arvind Bagga
12 Jul 2019 Author responded Author comments - China Nagano
Resubmission - Version 4
12 Jul 2019 Submitted Manuscript version 4
18 Jul 2019 Author responded Author comments - China Nagano
Resubmission - Version 5
18 Jul 2019 Submitted Manuscript version 5
Publishing
19 Jul 2019 Editorially accepted
2 Aug 2019 Article published 10.1186/s12882-019-1470-3

You can find further information about peer review here.

Back to article page